US Dollar vs Yen

登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。

登録

ホーム
投資
株式
アメリカ
NASDAQ
Amryt Pharma PLC (AMYT)
Amryt Pharma PLC (AMYT) ニュース

AMYT

Amryt Pharma (AMYT)

Amryt Pharma PLC

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:AMYT

1 2 3 4 5 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2023/04/19	06 : 02	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	NASDAQ:AMYT	Amryt Pharma PLC
2023/04/19	06 : 01	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	NASDAQ:AMYT	Amryt Pharma PLC
2023/04/19	05 : 16	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:AMYT	Amryt Pharma PLC
2023/04/13	06 : 29	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:AMYT	Amryt Pharma PLC
2023/04/12	21 : 21	Edgar (US Regulatory)	Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)	NASDAQ:AMYT	Amryt Pharma PLC
2023/04/12	20 : 58	PR Newswire (US)	Chiesi Farmaceutici S.p.A. Completes Acquisition of Amryt Pharma Plc	NASDAQ:AMYT	Amryt Pharma PLC
2023/04/12	20 : 00	GlobeNewswire Inc.	Chiesi Farmaceutici S.p.A. Completes Acquisition of Amryt Pharma Plc	NASDAQ:AMYT	Amryt Pharma PLC
2023/04/11	22 : 00	GlobeNewswire Inc.	2022 for Chiesi: The Group’s international growth continues	NASDAQ:AMYT	Amryt Pharma PLC
2023/04/03	22 : 01	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:AMYT	Amryt Pharma PLC
2023/03/23	22 : 01	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:AMYT	Amryt Pharma PLC
2023/02/16	21 : 01	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:AMYT	Amryt Pharma PLC
2023/02/14	00 : 25	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:AMYT	Amryt Pharma PLC
2023/02/11	06 : 02	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:AMYT	Amryt Pharma PLC
2023/02/10	23 : 49	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:AMYT	Amryt Pharma PLC
2023/01/10	06 : 06	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:AMYT	Amryt Pharma PLC
2022/11/07	12 : 35	TipRanks	SVB Securities Keeps Their Buy Rating on Amryt Pharma (AMYT)	NASDAQ:AMYT	Amryt Pharma PLC
2022/11/05	03 : 55	TipRanks	Amryt Pharma (AMYT) Receives a Buy from Maxim Group	NASDAQ:AMYT	Amryt Pharma PLC
2022/11/04	19 : 25	TipRanks	Amryt Pharma (AMYT) Receives a Buy from H.C. Wainwright	NASDAQ:AMYT	Amryt Pharma PLC
2022/11/03	20 : 45	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:AMYT	Amryt Pharma PLC
2022/09/19	19 : 25	TipRanks	H.C. Wainwright Sticks to Its Buy Rating for Amryt Pharma (AMYT)	NASDAQ:AMYT	Amryt Pharma PLC
2022/08/08	21 : 27	TipRanks	H.C. Wainwright Keeps Their Buy Rating on Amryt Pharma (AMYT)	NASDAQ:AMYT	Amryt Pharma PLC
2022/08/06	02 : 25	TipRanks	Maxim Group Reiterates a Buy Rating on Amryt Pharma (AMYT)	NASDAQ:AMYT	Amryt Pharma PLC
2022/07/14	20 : 49	Dow Jones News	Amryt Gets FDA Orphan Designation for Mycapssa in Carcinoid Syndrome	NASDAQ:AMYT	Amryt Pharma PLC
2022/06/26	16 : 39	TipRanks	SVB Securities Keeps a Buy Rating on Amryt Pharma (AMYT)	NASDAQ:AMYT	Amryt Pharma PLC
2022/06/24	20 : 54	Dow Jones News	Amryt to Pursue Formal FDA Resolution for Oleogel-S10	NASDAQ:AMYT	Amryt Pharma PLC
2022/06/24	20 : 19	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:AMYT	Amryt Pharma PLC
2022/06/23	20 : 26	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:AMYT	Amryt Pharma PLC
2022/05/23	19 : 04	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:AMYT	Amryt Pharma PLC
2022/05/21	06 : 07	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(4) (424b4)	NASDAQ:AMYT	Amryt Pharma PLC
2022/05/21	05 : 59	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(4) (424b4)	NASDAQ:AMYT	Amryt Pharma PLC

Showing the most relevant articles for your search:NASDAQ:AMYT

1 2 3 4 5 次へ >>

Blackhawk Growth (PK)

DB X-TR.MSCI MEX.TRN I.1C

CI Health Care Giants Co...

One World Lithium

TriLinc Global Impact Fu... (PK)

Energy One (PK)

Midwest Lithium

SUZBE515 Ex:51,51

Imperium Technology (PK)

WisdomTree Long JPY Shor...

Essence VII BV 0.3% 09ju...

Vontobel Financial Produ...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約